Get started
Author

Joe D. Lukowski

Observed names: J. D. Lukowski, Joe Lukowski
ORCID: 0000-0001-7112-3591
Observed ORCID: 0000-0001-7112-3591
OpenAlex ID: A5115004040
Pembrolizumab Gemcitabine Vinorelbine and Liposomal Doxorubicin (P-GVD) for Classical Hodgkin Lymphoma (CHL) in the Real-World Setting
2024 · Grace T. Baek, Gaurav Varma, et al. · Blood · 3
PDF
Real World Outcomes and Predictive Factors of Pirtobrutinib in Mantle Cell Lymphoma After Failure of Covalent Bruton Tyrosine Kinase Inhibitors
2026 · Tycel Phillips, Paolo Lopedote, et al. · Research Square
PDF
Outcomes in early stage peripheral T-cell lymphoma by stage, histology, and treatment patterns
2026 · Robert Stuver, Zachary R. Moore, et al. · Haematologica
PDF
Real-world evidence for pembrolizumab gemcitabine vinorelbine and liposomal doxorubicin in classical Hodgkin lymphoma
2026 · Grace Baek, Gaurav Varma, et al. · Blood Advances
The use of peripheral intravenous catheters (PIV) for lymphoma patients receiving anthracycline-based chemotherapy: A multicenter real-world analysis (RWA).
2025 · Yun Kyoung Ryu Tiger, Patrick Glennan, et al. · JCO Oncology Practice
892 | the Use of Peripheral Intravenous Catheters for Lymphoma Patients Receiving Anthracycline‐based Chemotherapy: a Multicenter Real‐world Analysis
2025 · Y. K. Tiger, J. D. Lukowski, et al. · Hematological Oncology
PDF
The use of peripheral intravenous catheters (PIV) for lymphoma patients receiving anthracycline-based chemotherapy: A multicenter real-world analysis (RWA).
2025 · Yun Kyoung Ryu Tiger, Joe D. Lukowski, et al. · Journal of Clinical Oncology
PDF
Concomitant Use of Antibiotics During Immune Checkpoint Inhibitor (CPI)-Based Salvage Therapy Does Not Impact Post-ASCT Outcomes in Patients with Relapsed/Refractory Hodgkin Lymphoma (RRHL)
2024 · Gaurav Varma, Maya C. Rosenberg, et al. · Blood
Works count: 8
Citation count: 3
H-index: 1
I10-index:
Year
Topic
Type